Trial Profile
Effects of Losartan versus Nebivolol versus the association of both on the progression of aortic root dilation in Marfan Syndrome (MFS) with FBN1 gene mutations
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 May 2016
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Nebivolol (Primary)
- Indications Marfan syndrome
- Focus Therapeutic Use
- 05 May 2016 New trial record